Literature DB >> 27219865

High prevalence of diffuse large B-cell lymphoma in occult hepatitis B virus-infected patients in the Tohoku district in Eastern Japan.

Katsushi Tajima1,2, Naoto Takahashi3, Kenichi Ishizawa4, Kazunori Murai5, Tomoaki Akagi6, Hideyoshi Noji7, Osamu Sasaki8, Masaharu Wano9, Jugoh Itoh10, Yuichi Kato11, Tsutomu Scichishima7, Yoji Ishida5, Hideo Harigae4, Kenichi Sawada3.   

Abstract

Occult hepatitis B virus (HBV) infection is a clinical challenge, but its relationship to clinicopathologic features and the risk of progression to malignant lymphoma (ML) are poorly defined. We estimated the prevalence of HBV infection of 1,358 patients with newly diagnosed ML. HBV infection was more prevalent in ML than in control patients. The occult HBV infection group had a higher median onset age, no liver or spleen involvement, and higher prevalence of diffuse large B-cell lymphoma than the other groups, indicating that occult HBV infection is a distinct clinicopathologic entity. J. Med. Virol. 88:2206-2210, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  clinicopathologic features; diffuse large B-cell lymphoma; hepatitis B virus; malignant lymphoma; occult HBV infection

Mesh:

Substances:

Year:  2016        PMID: 27219865     DOI: 10.1002/jmv.24584

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

Review 1.  Optimizing antiviral agents for hepatitis B management in malignant lymphomas.

Authors:  Oluwatobi O Ozoya; Julio Chavez; Lubomir Sokol; Samir Dalia
Journal:  Ann Transl Med       Date:  2017-02

2.  PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection.

Authors:  Zhihe Liu; Siyun Li; Yingmin Liu; Wei Guo; Ou Bai
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

3.  Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.

Authors:  Ting-Xun Lu; Shuang Wu; Dong-Yan Cai; Ting-Ting Hong; Ying Zhang; Hua-Qiang Gao; Hai-Ying Hua; Xiao-Hong Wu
Journal:  BMC Cancer       Date:  2019-06-08       Impact factor: 4.430

4.  Hepatitis B virus infection among oncohematologic disease patients in Central Brazil: prevalence, risk factors and immunization.

Authors:  Grécia C Pessoni; Tássia A Marinho; Megmar M Santos Carneiro; Regina M Martins; Caroline C Soares; Leandro N Silva; Marcia A Matos; Adriano M Arantes; Juliana A Teles; Nathalia C Santos; Sheila Araujo Teles
Journal:  Hematol Transfus Cell Ther       Date:  2019-03-28

5.  Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection.

Authors:  Mahua Sinha; Keerthana Sundar; C S Premalata; Vikas Asati; Alka Murali; Akhilesh Kumar Bajpai; Sravanthi Davuluri; Kshitish K Acharya; K C Lakshmaiah; Govind Babu K; Linu A Jacob; Dharam Nandan; Dinesh Velayutham; Sibnarayan Datta; R S Jayshree
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.